New York State Common Retirement Fund Coherus Bio Sciences, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 111,178 shares of CHRS stock, worth $163,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,178

Previous 111,178 -0.0%

Holding current value

$163,431

Previous $192,000 39.58%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$1.58 - $2.51 $112 - $178	71 Added 0.06%	111,178 $192,000
Q1 2024 May 07, 2024	SELL	$2.02 - $3.14 $208 - $323	-103 Reduced 0.09%	111,107 $266,000
Q4 2023 Feb 01, 2024	SELL	$1.59 - $3.85 $200 - $485	-126 Reduced 0.11%	111,210 $370,000
Q3 2023 Nov 07, 2023	SELL	$3.74 - $5.45 $1,193 - $1,738	-319 Reduced 0.29%	111,336 $416,000
Q2 2023 Aug 07, 2023	BUY	$3.79 - $8.3 $12,999 - $28,469	3,430 Added 3.17%	111,655 $477,000
Q1 2023 May 02, 2023	BUY	$5.89 - $10.52 $36,423 - $65,055	6,184 Added 6.06%	108,225 $740,000
Q3 2022 Nov 08, 2022	SELL	$7.17 - $13.87 $249,931 - $483,480	-34,858 Reduced 25.46%	102,041 $981,000
Q2 2022 Aug 04, 2022	SELL	$5.86 - $13.23 $51,550 - $116,384	-8,797 Reduced 6.04%	136,899 $991,000
Q1 2022 May 05, 2022	SELL	$10.92 - $16.41 $254,501 - $382,451	-23,306 Reduced 13.79%	145,696 $1.88 Million
Q4 2021 Feb 02, 2022	BUY	$15.81 - $18.99 $82,986 - $99,678	5,249 Added 3.21%	169,002 $2.7 Million
Q3 2021 Nov 02, 2021	BUY	$12.68 - $17.79 $493,746 - $692,724	38,939 Added 31.2%	163,753 $2.63 Million
Q2 2021 Aug 02, 2021	BUY	$12.95 - $15.41 $186,298 - $221,688	14,386 Added 13.03%	124,814 $1.73 Million
Q1 2021 May 11, 2021	BUY	$14.42 - $21.39 $327,045 - $485,125	22,680 Added 25.85%	110,428 $1.61 Million
Q4 2020 Feb 08, 2021	SELL	$16.56 - $18.94 $422,279 - $482,970	-25,500 Reduced 22.52%	87,748 $1.53 Million
Q3 2020 Nov 05, 2020	BUY	$17.41 - $19.89 $408,630 - $466,838	23,471 Added 26.14%	113,248 $2.08 Million
Q2 2020 Aug 07, 2020	BUY	$14.43 - $19.16 $33,607 - $44,623	2,329 Added 2.66%	89,777 $1.6 Million
Q1 2020 May 06, 2020	BUY	$11.67 - $22.53 $259,109 - $500,233	22,203 Added 34.03%	87,448 $1.42 Million
Q4 2019 Feb 05, 2020	BUY	$16.33 - $21.37 $30,128 - $39,427	1,845 Added 2.91%	65,245 $1.18 Million
Q2 2019 Aug 09, 2019	BUY	$13.1 - $22.1 $182,090 - $307,190	13,900 Added 28.08%	63,400 $1.4 Million
Q4 2018 Feb 08, 2019	SELL	$8.65 - $16.28 $22,490 - $42,328	-2,600 Reduced 4.99%	49,500 $448,000
Q2 2018 Aug 10, 2018	BUY	$10.25 - $17.45 $108,650 - $184,970	10,600 Added 25.54%	52,100 $729,000
Q1 2018 May 10, 2018	SELL	$9.1 - $13.7 $19,110 - $28,770	-2,100 Reduced 4.82%	41,500 $459,000
Q2 2017 Aug 11, 2017	BUY	N/A	43,600	43,600 $626,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $114M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Coherus Bio Sciences, Inc. Transaction History